Senescent Cells: Therapeutic Target, Biological Signal, or Red Herring? Longevity Series Brief Summary This article explores one of the most intriguing questions in modern geroscience: whether senescent cells are actionable therapeutic targets or merely biological bystanders associated with aging and chronic disease. The answer
Tag: biomarkers
Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer’s Patient
Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer's Patient Review Abstract Alzheimer's disease is often marked by progressive episodic memory loss, but not all patients start with an amnestic syndrome. Some patients may initially present with issues in visual-spatial skills, language, executive function,
The Great Biomarker Boom: Are We Overdiagnosing Risk or Finally Personalizing Medicine?
The Great Biomarker Boom: Are We Overdiagnosing Risk or Finally Personalizing Medicine? Review Abstract The rapid expansion of biomarker discovery and clinical application has created both unprecedented opportunities and substantial challenges in modern medicine. This analysis examines whether the current biomarker boom represents genuine progress
Anastomotic Leak Prediction: Biomarkers + AI vs Surgeon Judgment
Anastomotic Leak Prediction: Biomarkers + AI vs Surgeon Judgment Key Takeaways Anastomotic leak prediction is evolving rapidly, with three distinct approaches showing different strengths and implementation timelines for surgical practice. AI models achieve 99.6% accuracy but face practical barriers. Biomarker protocols offer negative predictive
ALS News: Breakthrough Drug Shows Promising Results in Clinical Trials
ALS News: Breakthrough Drug Shows Promising Results in Clinical Trials Introduction Recent ALS news reveals a groundbreaking personalized drug therapy that has demonstrated remarkable efficacy in slowing ALS progression. In April 2024, a patient received the first-ever antisense oligonucleotide (ASO) treatment targeting CHCHD10 mutations in
Long COVID: Sorting Real Symptoms from Diagnostic Chaos
